What’s New for SEND 2023
This webinar will focus on several changes to the CDISC SEND standard that became active…
CertaraJune 12, 2023
Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program
Certara's support, from dose optimization to medical writing, helps pharmaceutical companies advance their research, make…
CertaraJune 1, 2023
SEND Dataset Quality Control: Best Practices & Recommendations
In this blog, Senior Product Management Director Peggy Zorn explores best practices & recommendations for…
CertaraApril 25, 2023
Repurposing Data & Advanced Analytics to Validate Surrogate Endpoints
Repurposed data and advanced analytics can be used to validate a surrogate endpoint. A surrogate…
CertaraApril 13, 2023
LABO: Data utilisation and data infrastructure in drug development: Data, Data, Data
Published: April 12, 2023 This is the German article written by Dr. Fabian Rauscher, Scientific…
CertaraApril 12, 2023
Data Visualization with SEND Data to See What Happened at the Preclinical Phase
SEND is an implementation of CDISC’s (Clinical Data Interchange Standards Consortium) SDTM (Study Data Tabulation…
CertaraFebruary 9, 2023
The eCTD Submission Process: Tips and Tricks for Drug Development Success
Our experts compiled the tips and best practices you need to know for a successful…
CertaraNovember 22, 2022
Providing Around-the-Clock Regulatory Support While Enhancing Team Chemistry
Advaxis Inc. is devoted to the discovery, development, and commercialization of immunotherapies based on a…
CertaraJune 3, 2022
PBPK Modeling in Adults Enables DDI Risk Assessment in Children with SMA
In 2020, the US FDA approved Risdiplam (Evrysdi®) as the first orally administered drug to…
CertaraJune 2, 2022
